Rick Wise
Stock Analyst at Stifel
(4.10)
# 457
Out of 5,172 analysts
268
Total ratings
58.72%
Success rate
8.99%
Average return
Main Sectors:
Stocks Rated by Rick Wise
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $110 → $90 | $69.48 | +29.53% | 19 | Mar 20, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $98 | $69.65 | +40.70% | 4 | Feb 5, 2026 | |
| JNJ Johnson & Johnson | Maintains: Hold | $205 → $220 | $235.37 | -6.53% | 8 | Jan 22, 2026 | |
| EW Edwards Lifesciences | Maintains: Buy | $105 → $110 | $82.50 | +33.33% | 29 | Jan 20, 2026 | |
| MDLN Medline | Initiates: Buy | $46 | $42.73 | +7.65% | 1 | Jan 12, 2026 | |
| TMCI Treace Medical Concepts | Maintains: Hold | $5 → $3 | $1.24 | +141.94% | 10 | Jan 7, 2026 | |
| SOLV Solventum | Maintains: Buy | $88 → $105 | $65.78 | +59.62% | 2 | Jan 7, 2026 | |
| OM Outset Medical | Maintains: Buy | $14 → $8 | $3.36 | +138.10% | 6 | Jan 7, 2026 | |
| LIVN LivaNova | Maintains: Buy | $65 → $70 | $62.19 | +12.56% | 7 | Jan 7, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $210 → $215 | $154.13 | +39.49% | 9 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $40 | $26.02 | +53.73% | 2 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $20 | $16.52 | +21.07% | 7 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $90 → $105 | $86.16 | +21.87% | 12 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $46 | $35.31 | +30.27% | 8 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $118 | $87.87 | +34.29% | 16 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $36 → $25 | $16.15 | +54.80% | 9 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $5 | $1.36 | +267.65% | 5 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $75 → $55 | $35.94 | +53.03% | 12 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $105.46 | +37.49% | 21 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $19.10 | +46.60% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $48 | $29.18 | +64.52% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $400 → $440 | $335.67 | +31.08% | 16 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $525 → $610 | $477.97 | +27.62% | 17 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $170 → $190 | $178.24 | +6.60% | 14 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $9 → $12 | $5.06 | +137.15% | 3 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $59 → $75 | $106.31 | -29.45% | 1 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $17 → $24 | $24.82 | -3.30% | 7 | Feb 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $25 | $13.05 | +91.57% | 4 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $103 → $112 | $56.95 | +96.66% | 5 | Oct 2, 2020 |
Boston Scientific
Mar 20, 2026
Maintains: Buy
Price Target: $110 → $90
Current: $69.48
Upside: +29.53%
GE HealthCare Technologies
Feb 5, 2026
Maintains: Buy
Price Target: $95 → $98
Current: $69.65
Upside: +40.70%
Johnson & Johnson
Jan 22, 2026
Maintains: Hold
Price Target: $205 → $220
Current: $235.37
Upside: -6.53%
Edwards Lifesciences
Jan 20, 2026
Maintains: Buy
Price Target: $105 → $110
Current: $82.50
Upside: +33.33%
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $46
Current: $42.73
Upside: +7.65%
Treace Medical Concepts
Jan 7, 2026
Maintains: Hold
Price Target: $5 → $3
Current: $1.24
Upside: +141.94%
Solventum
Jan 7, 2026
Maintains: Buy
Price Target: $88 → $105
Current: $65.78
Upside: +59.62%
Outset Medical
Jan 7, 2026
Maintains: Buy
Price Target: $14 → $8
Current: $3.36
Upside: +138.10%
LivaNova
Jan 7, 2026
Maintains: Buy
Price Target: $65 → $70
Current: $62.19
Upside: +12.56%
Becton, Dickinson and Company
Jan 7, 2026
Maintains: Buy
Price Target: $210 → $215
Current: $154.13
Upside: +39.49%
Nov 13, 2025
Maintains: Buy
Price Target: $35 → $40
Current: $26.02
Upside: +53.73%
Oct 10, 2025
Maintains: Buy
Price Target: $32 → $20
Current: $16.52
Upside: +21.07%
Oct 9, 2025
Maintains: Hold
Price Target: $90 → $105
Current: $86.16
Upside: +21.87%
Sep 29, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $35.31
Upside: +30.27%
Sep 19, 2025
Maintains: Buy
Price Target: $115 → $118
Current: $87.87
Upside: +34.29%
Aug 4, 2025
Downgrades: Hold
Price Target: $36 → $25
Current: $16.15
Upside: +54.80%
Jul 31, 2025
Maintains: Buy
Price Target: $16 → $5
Current: $1.36
Upside: +267.65%
Apr 28, 2025
Downgrades: Hold
Price Target: $75 → $55
Current: $35.94
Upside: +53.03%
Apr 17, 2025
Maintains: Buy
Price Target: $135 → $145
Current: $105.46
Upside: +37.49%
Mar 31, 2025
Initiates: Buy
Price Target: $28
Current: $19.10
Upside: +46.60%
Feb 13, 2025
Maintains: Buy
Price Target: $36 → $48
Current: $29.18
Upside: +64.52%
Jan 29, 2025
Maintains: Buy
Price Target: $400 → $440
Current: $335.67
Upside: +31.08%
Dec 5, 2024
Maintains: Buy
Price Target: $525 → $610
Current: $477.97
Upside: +27.62%
Nov 22, 2024
Reiterates: Buy
Price Target: $170 → $190
Current: $178.24
Upside: +6.60%
Jul 16, 2024
Upgrades: Buy
Price Target: $9 → $12
Current: $5.06
Upside: +137.15%
Apr 26, 2024
Upgrades: Buy
Price Target: $59 → $75
Current: $106.31
Upside: -29.45%
Feb 5, 2024
Maintains: Hold
Price Target: $17 → $24
Current: $24.82
Upside: -3.30%
Jun 21, 2023
Reiterates: Hold
Price Target: $25
Current: $13.05
Upside: +91.57%
Oct 2, 2020
Maintains: Hold
Price Target: $103 → $112
Current: $56.95
Upside: +96.66%